Cargando…

Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment

OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Aman, Al Kury, Lina Tariq, Althobaiti, Yusuf S, Ali, Tahir, Shah, Fawad ALi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286489/
https://www.ncbi.nlm.nih.gov/pubmed/35845091
http://dx.doi.org/10.2147/JIR.S351913
_version_ 1784748023429988352
author Ullah, Aman
Al Kury, Lina Tariq
Althobaiti, Yusuf S
Ali, Tahir
Shah, Fawad ALi
author_facet Ullah, Aman
Al Kury, Lina Tariq
Althobaiti, Yusuf S
Ali, Tahir
Shah, Fawad ALi
author_sort Ullah, Aman
collection PubMed
description OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and oxidative stress. Targeting neuroinflammation and oxidative stress may be a useful strategy for preventing ethanol-induced neurodegeneration. METHODOLOGY: Firstly, the newly synthesized compounds were subjected to molecular simulation and docking in order to predict ligand binding status. Later, for in vivo observations, adult male Sprague Dawley rats were used for studying behavioral and oxidative stress markers. ELIZA kits were used to analyse tumour necrosis factor-alpha (TNF-), nuclear factor-B (NF-B), interleukin (IL-18), and pyrin domain-containing protein 3 (NLRP3) expression, while Western blotting was used to measure IL-1 and Caspase-1 expression. RESULTS: Our findings suggested that altered levels of antioxidant enzymes were associated with elevated levels of TNF-α, NF-B, IL-1, IL-18, Caspase-1, and NLRP3 in the ethanol-treated group. Furthermore, ethanol also caused memory impairment in rats, as measured by behavioural tests. Pretreatment using selected benzimidazole significantly increased the combat of the brain against ethanol-induced oxidative stress. The neuroprotective effects of benzimidazole derivatives were promoted by their free radical scavenging activity, augmentation of endogenous antioxidant proteins (GST, GSH), and amelioration of lipid peroxide (LPO) and other pro-inflammatory mediators. Molecular docking and molecular simulation studies further supported our hypothesis that the synthetic compounds Ca and Cb had an excellent binding affinity with proper bond formation with their targets (TNF-α and NLRP3). CONCLUSION: It is revealed that these benzimidazole derivatives can reduce ethanol-induced neuronal toxicity by regulating the expression of cytokines, antioxidant enzymes, and the inflammatory cascade.
format Online
Article
Text
id pubmed-9286489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92864892022-07-16 Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment Ullah, Aman Al Kury, Lina Tariq Althobaiti, Yusuf S Ali, Tahir Shah, Fawad ALi J Inflamm Res Original Research OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and oxidative stress. Targeting neuroinflammation and oxidative stress may be a useful strategy for preventing ethanol-induced neurodegeneration. METHODOLOGY: Firstly, the newly synthesized compounds were subjected to molecular simulation and docking in order to predict ligand binding status. Later, for in vivo observations, adult male Sprague Dawley rats were used for studying behavioral and oxidative stress markers. ELIZA kits were used to analyse tumour necrosis factor-alpha (TNF-), nuclear factor-B (NF-B), interleukin (IL-18), and pyrin domain-containing protein 3 (NLRP3) expression, while Western blotting was used to measure IL-1 and Caspase-1 expression. RESULTS: Our findings suggested that altered levels of antioxidant enzymes were associated with elevated levels of TNF-α, NF-B, IL-1, IL-18, Caspase-1, and NLRP3 in the ethanol-treated group. Furthermore, ethanol also caused memory impairment in rats, as measured by behavioural tests. Pretreatment using selected benzimidazole significantly increased the combat of the brain against ethanol-induced oxidative stress. The neuroprotective effects of benzimidazole derivatives were promoted by their free radical scavenging activity, augmentation of endogenous antioxidant proteins (GST, GSH), and amelioration of lipid peroxide (LPO) and other pro-inflammatory mediators. Molecular docking and molecular simulation studies further supported our hypothesis that the synthetic compounds Ca and Cb had an excellent binding affinity with proper bond formation with their targets (TNF-α and NLRP3). CONCLUSION: It is revealed that these benzimidazole derivatives can reduce ethanol-induced neuronal toxicity by regulating the expression of cytokines, antioxidant enzymes, and the inflammatory cascade. Dove 2022-07-11 /pmc/articles/PMC9286489/ /pubmed/35845091 http://dx.doi.org/10.2147/JIR.S351913 Text en © 2022 Ullah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ullah, Aman
Al Kury, Lina Tariq
Althobaiti, Yusuf S
Ali, Tahir
Shah, Fawad ALi
Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title_full Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title_fullStr Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title_full_unstemmed Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title_short Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
title_sort benzimidazole derivatives as new potential nlrp3 inflammasome inhibitors that provide neuroprotection in a rodent model of neurodegeneration and memory impairment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286489/
https://www.ncbi.nlm.nih.gov/pubmed/35845091
http://dx.doi.org/10.2147/JIR.S351913
work_keys_str_mv AT ullahaman benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment
AT alkurylinatariq benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment
AT althobaitiyusufs benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment
AT alitahir benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment
AT shahfawadali benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment